Content Area

Label: VARDENAFIL tablet, orally disintegrating

Other > vardenafil 10 mg tablet


lenacapavir will increase the level or effect

  • The onset of vardenafil 10 mg is typically 30-60 minutes.
  • It can last up to 4-5 hours in some users.
  • Vardenafil is contraindicated with certain heart medications.
  • Use caution if you have a history of hypotension.
  • The tablet may cause mild gastrointestinal upset.
  • Do not consume large amounts of alcohol when taking vardenafil.
  • Inform your doctor if you experience sudden hearing loss.
  • Use only as directed by your healthcare provider.
  • Discontinue if you experience persistent erection issues.
  • The medication does not increase sexual desire.

of vardenafil by affecting

  • Vardenafil 10 mg is one of several ED treatment options.
  • It is generally well-tolerated when used properly.
  • Take care to follow your healthcare provider’s instructions.
  • Possible interactions with antihypertensive drugs exist.
  • Do not drive or operate machinery if feeling dizzy.
  • Keep a record of any side effects experienced.
  • The medication is not a cure for erectile dysfunction.
  • Combining vardenafil with other ED drugs is dangerous.
  • Take the tablet with a full glass of water.
  • Consult your doctor for dose adjustments if needed.

hepatic/intestinal enzyme CYP3A4 metabolism.

Can erectile dysfunction be a sign of another health condition?

ivacaftorivacaftor will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil vardenafil pills dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors ivacaftor will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors ketoconazoleketoconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. ketoconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lapatiniblapatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Limit vardenafil dose to 2.5 mg/24

Product Dosage Quantity + Bonus Price
Kamagra Soft Tabs100 mg12 Pills57.55€ 54.81€
Cialis Black80mg90 + 6 Pills207.88€ 197.98€
Levitra Original20mg34 + 2 Pills188.51€ 179.53€
Cialis Soft Tabs20mg270 + 10 Pills471.40€ 448.95€
Viagra Professional100mg10 Pills44.09€ 41.99€
Cialis Professional40mg30 Pills148.94€ 141.85€
Levitra Generic10mg60 + 6 Pills112.98€ 107.60€
Kamagra Soft Tabs100mg12 Pills57.55€ 54.81€
Levitra Generic20mg180 + 10 Pills293.10€ 279.14€
Viagra Oral Jelly100mg110 + 9 Sachets284.63€ 271.08€
Cialis Generic5mg120 + 6 Pills132.92€ 126.59€

lithiumlithium and vardenafil both increase QTc interval.

  • Some users may experience mild flickering vision episodes.
  • The efficacy of vardenafil varies between individuals.
  • The medication is available in various dosage forms.
  • Always follow the specific instructions provided.
  • Avoid taking vardenafil with high-fat meals to speed absorption.
  • Do not take vardenafil if allergic to its ingredients.
  • The drug may cause a temporary burning sensation.
  • Use caution in patients with a history of priapism.
  • Avoid combining vardenafil with certain herbal supplements.
  • Consult your doctor about any ongoing health treatments.

lithium and vardenafil both increase QTc interval.

8.7 Renal Impairment

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors lapatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors larotrectiniblarotrectinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors larotrectinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors lenacapavirlenacapavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Lencapavir may increase CYP3A4 substrates initiated within 9 months after last SC dose of lenacapavir, which may increase potential risk of adverse reactions of CYP3A4 substrates. lonafarniblonafarnib will increase the level or effect

What is the current market landscape for vardenafil hydrochloride?

haloperidol and vardenafil both increase QTc interval. hydrocortisonehydrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. hydrocortisone will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. hydroxyzinehydroxyzine and vardenafil both increase QTc interval. hydroxyzine and vardenafil both increase QTc interval.

From Rybelsus to the Ozempic Pill: What Pharmacists Need to Know About the Next Generation of Oral Semaglutide

ibrexafungerpibrexafungerp will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors imatinibimatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors imatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors Drugs that are known to prolong the QTc interval may have an increased the risk of ventricular arrhythmias. Drugs that are known to prolong the vardenafil oral QTc interval may have an increased the risk of ventricular arrhythmias. of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

  • Vardenafil 10 mg tablets treat erectile dysfunction in men.
  • The medication works by increasing blood flow to the penis.
  • Take vardenafil 10 mg about 30 minutes before activity.
  • It can be taken with or without food, but high-fat meals may delay effects.
  • Maximum recommended dose is one tablet per 24 hours.
  • Vardenafil may cause side effects like headache or flushing.
  • Do not use vardenafil if you take nitrates for chest pain.
  • Consult a doctor before using vardenafil if you have heart problems.
  • Store vardenafil tablets at room temperature, away from moisture.
  • Alcohol can increase side effects of vardenafil.

If coadministration unavoidable, monitor for adverse reactions and reduce CYP3A substrate dose in accordance with product labeling.

Drug Name Dose Range Duration of Action Onset Time Special Features
Vardenafil 5-20 mg 4-5 hours 30-60 min Fast onset, good for food timing
Sildenafil 25-100 mg 4-6 hours 30-60 min Well-studied, widespread use
Tadalafil 2.5-20 mg Up to 36 hours 30-120 min Long duration, daily options
Avanafil 50-200 mg 4-6 hours 15-30 min Fastest onset, fewer side effects

lonafarnib will increase the level or effect

What are the accompanying risks?

fostamatinibfostamatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fostamatinib will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fostemsavirvardenafil and fostemsavir both increase QTc interval. QTc prolongation reported with higher than recommended doses of fostemsavir. vardenafil and fostemsavir both fildena 150 mg tablet increase QTc interval.

Subscribe to MedicineNet's Men's Health Newsletter

gemifloxacingemifloxacin and vardenafil both increase QTc interval. gemifloxacin and vardenafil both increase QTc interval. gepirone and vardenafil both increase QTc interval. gepotidacingepotidacin increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If possible, avoid with sensitive substrates that are are extensively metabolized by CYP3A4 and have a narrow therapeutic index. of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Usual Geriatric Dose for Erectile Dysfunction

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors isavuconazonium sulfate will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors isoniazidisoniazid will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors isoniazid will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors istradefyllineistradefylline will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Istradefylline 40 mg/day increased peak levels and AUC of CYP3A4 substrates in clinical trials.

Who should not take vardenafil?

This effect was not observed with istradefylline 20 mg/day. Consider dose reduction of sensitive CYP3A4 substrates. istradefylline will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. itraconazoleitraconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. itraconazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. lopinavirlopinavir will increase the level or effect

12.1 Mechanism of Action

If unable to avoid, monitor or modify substrate dose according to its prescribing information. gepotidacin increases levels of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. gilteritinib and vardenafil both increase QTc interval. granisetrongranisetron and vardenafil both increase QTc interval. granisetron and vardenafil both increase QTc interval.

Pregnancy and breastfeeding

grapefruitgrapefruit will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. grapefruit will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvingriseofulvin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. griseofulvin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. haloperidolhaloperidol and vardenafil both increase QTc interval. of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

What should I avoid while using vardenafil?

fluvoxaminefluvoxamine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fluvoxamine will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosamprenavirfosamprenavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosamprenavir will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosaprepitantfosaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

Erectile Dysfunction

Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosaprepitant will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Vardenafil dose may need to be reduced if coadministered with moderate or strong CYP3A4 inhibitors fosfomycinfosfomycin and vardenafil both increase QTc interval. The risk of QT prolongation may increase in patients with electrolyte abnormalities (such as hypokalemia and hypocalcemia), patients with conditions that have potential to cause electrolyte imbalance (such as renal impairment), or patients taking other drugs affecting electrolyte balance or QT prolongation; avoid this drug in patients with known QT prolongation or ventricular arrhythmias, including a history of torsade de pointes; monitor electrolytes during treatment fosfomycin and vardenafil both increase QTc interval. The risk of QT prolongation may increase in patients with electrolyte abnormalities (such as hypokalemia and hypocalcemia), patients with conditions that have potential to cause electrolyte imbalance (such as renal impairment), or patients taking other drugs affecting electrolyte balance or QT prolongation; avoid this drug in patients with known QT prolongation or ventricular arrhythmias, including a history of torsade de pointes; monitor electrolytes during treatment fosphenytoinfosphenytoin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. fosphenytoin will decrease the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.